Isn’t it shocking that the Food and Drug Administration (FDA) approved Zulresso (Brexanolone) in March 2019? Who would have thought it would take this long to create a medication for Post-Partum Depression? After all, for how long have women been giving birth?
It is for others to lament the dearth of information about women’s health. That’s a whole other series of conversations. It is our stance to focus on celebrating breakthroughs.